BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $299M
- YoY, 2025
- +12.4%
- 5-year CAGR
- +12.0%
- 10-year CAGR
- +10.8%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $299M | +12.4% |
| 2024 | $266M | +14.2% |
| 2023 | $233M | +5.9% |
| 2022 | $220M | +13.4% |
| 2021 | $194M | +14.1% |
| 2020 | $170M | +8.3% |
| 2019 | $157M | +12.1% |
| 2018 | $140M | +10.2% |
| 2017 | $127M | +9.5% |
| 2016 | $116M | +8.4% |
| 2015 | $107M | +3.9% |
| 2014 | $103M | −1.9% |
| 2013 | $105M | −2.8% |
| 2012 | $108M | −15.6% |
| 2011 | $128M | −14.7% |
| 2010 | $150M | +4.2% |
| 2009 | $144M | +4.3% |
| 2008 | $138M | +13.1% |
| 2007 | $122M | — |